Tate & Lyle

Tate & Lyle PLC is a global provider of high-quality ingredients and solutions primarily for the food and beverage industries. The company operates through three main segments: Food & Beverage Solutions, Sucralose, and Primary Products. It specializes in offering a range of ingredients, including texturants, nutritive sweeteners, health and wellness components, stabilizers, and industrial starches. Additionally, Tate & Lyle supplies acidulants and various commodities for animal nutrition, such as corn gluten feed, corn oil, and ethanol. Following strategic divestments, Tate & Lyle has shifted its focus towards specialty ingredients, enhancing its innovation and product development capabilities. With a workforce of approximately 2,700 employees, the company operates in over 140 countries, generating most of its revenue in North America. It also has a venture capital arm, Tate & Lyle Ventures, which invests in early-stage companies in renewable ingredients and food technologies, supporting innovation in the industry. Established in 1903 and headquartered in London, Tate & Lyle continues to play a significant role in providing functional and nutritious solutions to meet global consumer demands.

David Atkinson

Managing Partner

Jeffrey Sands

Senior Vice President, Strategy and M&A

22 past transactions

Sweet Green Fields

Acquisition in 2020
Sweet Green Fields is a prominent global innovator specializing in stevia leaf extracts, focusing on creating natural sweeteners and food additives for the beverages, dairy, and snacks industries. Established in 1999, the company has developed proprietary stevia varieties through an extensive plant breeding program, which supports its commitment to delivering a taste that closely resembles sugar. By combining these innovative stevia extracts with food science, Sweet Green Fields aims to produce great-tasting sweeteners that cater to diverse consumer preferences. As a subsidiary of Tate & Lyle plc, the company continues to enhance its broad portfolio of stevia-based products, aligning with its mission to achieve exceptional flavor profiles.

Changing Health

Seed Round in 2018
Built on a robust base of scientific evidence, our programmes empower people with the tools and knowledge to make lasting lifestyle changes. We’ve combined health coaching rooted in behavioural psychology with engaging digital education, delivering outcomes that stand up to rigorous evaluation. This approach enables healthcare organisations around the world to deliver game-changing support at scale, making the most of scarce time and resources.

Evolve Biosystems

Series B in 2017
Evolve Biosystems, Inc. is a biotechnology company based in Davis, California, that focuses on developing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. The company specializes in addressing gut dysbiosis across all stages of life, with particular emphasis on supporting the microbiome of newborn infants. Evolve Biosystems offers both consumer-directed home use products and hospital-based solutions for neonatal intensive care units. With a discovery platform that also addresses microbiome issues in production animals, the company aims to meet various unmet clinical needs. Founded in 2011, Evolve Biosystems is committed to advancing microbiome health through innovative probiotic solutions.

Nutriati

Series A in 2017
Nutriati, Inc. is a food technology company based in Richmond, Virginia, established in 2013. The company specializes in researching, developing, producing, and commercializing innovative plant-based food ingredients, notably gluten-free chickpea protein and chickpea flour. Nutriati aims to create nutritious food products that appeal to a wide range of consumer tastes while promoting healthier ingredients in the food supply. The company is committed to making a positive social impact and improving global health and well-being through its offerings.

Evolve Biosystems

Series A in 2015
Evolve Biosystems, Inc. is a biotechnology company based in Davis, California, that focuses on developing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. The company specializes in addressing gut dysbiosis across all stages of life, with particular emphasis on supporting the microbiome of newborn infants. Evolve Biosystems offers both consumer-directed home use products and hospital-based solutions for neonatal intensive care units. With a discovery platform that also addresses microbiome issues in production animals, the company aims to meet various unmet clinical needs. Founded in 2011, Evolve Biosystems is committed to advancing microbiome health through innovative probiotic solutions.
Gemacom Tech Indústria e Comércio is a producer and supplier specializing in the development and manufacturing of stabilizing systems and ingredient blends for the food industry. The company offers a diverse range of products, including modified starches, aromas, colorants, fruit and jam preparations, toppings, sweet and savory fillings, thickeners, and stabilizers. Additionally, Gemacom Tech provides milk and whey protein concentrates, automatized powder mixtures, cheese pastes, and various condiments, catering to the needs of food manufacturers and processors. Through its extensive product offerings, the company aims to support the formulation and enhancement of food products in various market segments.

Winway Biotechnology Natong Co

Acquisition in 2014
Winway Biotechnology Natong Co. Ltd. manufactures and markets polydextrose specialty fiber. The company is based in Nantong, China.

Jiangsu Howbetter Food Co. Ltd.

Acquisition in 2013
Jiangsu Howbetter Food Co. Ltd. provides stabilizer systems and ingredient blends for the dairy and beverage industries.

Biovelop International

Acquisition in 2013
Biovelop International AB develops and produces oat beta glucan and other specialty ingredients. The company specializes in the fractionation of cereal grains to produce ingredients for use in food, beverages, nutritional supplements, cosmetics, and personal care products. Its products include PromOat, an active soluble fibre in oat bran for use in various foods, beverages, and nutritional supplement products to lower cholesterol, modulate blood sugar levels, and improve digestive health; and Avenacare, a liquid form of active oat beta glucan for use in cosmetics and personal care products to reduce skin irritation, soothe redness, and strengthen hair. The company also provides prOATein (oat protein), a non-dairy, non-GMO protein alternative for boosting the protein content of various nutritious products, including bars, bread, baked goods, meal replacement shakes, meat products, pasta, sports nutrition products, and supplements.

Lumora

Venture Round in 2013
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

Allylix

Venture Round in 2012
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Lumora

Series B in 2011
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

Allylix

Series C in 2010
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Aquapharm Biodiscovery

Series C in 2010
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.

Allylix

Series C in 2010
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Fugeia

Venture Round in 2008
Fugeia NV specializes in developing ingredients and nutrition technologies, focusing on arabinoxylan-oligosaccharides (AXOS), which offer various health benefits associated with wholegrain wheat. These benefits include potential prevention of lifestyle diseases such as diabetes, obesity, cardiovascular conditions, and cancer. The company has innovated technologies for prebiotic bread and AXOS-enriched beer, enhancing the levels of these beneficial compounds in these products. Fugeia's offerings cater to a wide range of market segments, including dairy and non-dairy beverages, ready-to-eat cereals, cookies, biscuits, bread, and pastries, as well as dietary supplements and therapeutics. Founded in 2008, the company is based in Heverlee, Belgium.

Allylix

Venture Round in 2007
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Aquapharm Biodiscovery

Series B in 2007
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.

G. C. Hahn & Co.

Acquisition in 2007
G. C. Hahn & Co. manufactures customized food stabilizer systems for the food industry. G. C. Hahn & Co. products are used in milk, delicatessen, ready meals, sauces and soups, bakery, meat products, beverages, filling aids, fish products, savory snacks, fruit products, food service, and ice cream applications.

Lumora

Venture Round in 2007
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

Cesalpinia food SpA

Acquisition in 2005
Cesalpinia food SpA manufactues and supplies food additives for food, pharmaceutical, and pet food industries. Cesalpinia food SpA provides gums, thickeners, stabilizers, jellifying agents, blends, and natural flours.

Continental Custom Ingredients

Acquisition in 2005
CCI is a recognised leader in dairy stabilisers and emulsifier systems and works closely with customers to develop ingredient systems for the North American market. CCI also has expertise in beverage flavours and vitamin and mineral fortification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.